A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
for Primary IgA Nephropathy
40 locations incl. Alabaster
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT05797610·Phase 3·Recruiting